Sandoz makes its first acquisition since spinning out of Novartis, buying a Lucentis biosimilar from Coherus that will boost its position in the US market.

Congressional Stock Trading: Who Trades and Makes the Most Members of Congress have beaten the market in recent years but their trades have come under growing scrutiny ...

How do I know I can trust these reviews about Cabela's World's Foremost Outfitter?